CRISPR toolmaker Synthego raises $110M Series C led by Peter Thiel’s VC fund

0
186
FDA green-lights CRISPR Therapeutics, Vertex Pharmaceuticals’ gene-editing study


The financing, led by Thiel’s Founders Fund, will help the company expand its reach into Europe and Asia while building up its manufacturing capabilities.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here